Drug Development
Page 1 • 4 itemsGain critical insights into global drug development trends, clinical trial advancements, regulatory hurdles, and R&D strategies for pharma investors and BD.
Biosimulation Market to Reach $11.3 Billion by 2031 as Pharmaceutical Companies Accelerate Digital Drug Development
The global biosimulation market will grow 16%+ annually to $11.3 billion by 2031, driven by pharmaceutical companies adopting digital modeling for faster drug development.
Novelty Nobility Expands AGC Biologics Partnership for Bispecific Antibody Manufacturing
South Korean biotech Novelty Nobility expands manufacturing deal with AGC Biologics to advance bispecific antibody candidate through GMP production in Japan.
Seragon's SRN-901 Longevity Drug Shows Significant Lifespan Extension in Preclinical Study
Seragon Biosciences' SRN-901 demonstrated significant lifespan and healthspan extension in mice, marking a breakthrough in longevity therapeutics development.
Drug Development Services Market Surges to $31.5 Billion in 2026, Driven by Pharmaceutical R&D Investments
Drug development services market grows 12.2% CAGR to reach $31.5 billion in 2026, fueled by increased pharmaceutical R&D spending and outsourcing trends.